Home-based Care Coaching for Chronic Obstructive Pulmonary Disease
Comprehensive Patient-Centered Home-based Care Coaching for COPD Self-management
Recruiting
N/A
Interventional Study
Chronic Obstructive Pulmonary Disease
At a Glance
- Age
- 40 and older
- Sex
- Any
- Study type
- Interventional
- Purpose
- Treatment
- Participants needed
- 300 (estimated)
- Sponsor
- Icahn School of Medicine at Mount Sinai · Other
Who this trial is looking for
This trial is looking for adults aged 40 and older with chronic obstructive pulmonary disease (COPD). Participants will receive home-based coaching to help manage their condition and improve their medication use.
Are You a Good Fit for This Trial?
You may be able to join if
- I am at least 40 years old.
- I have been diagnosed with COPD.
- I have been prescribed a long-acting muscarinic agonist (LAMA), long-acting beta-agonist (LABA), or an inhaled corticosteroid (ICS).
- I can speak English or Spanish.
You may not be able to join if
- I have dementia documented in my health records.
Summarized in plain language from this trial's official eligibility criteria. The full criteria are further down this page — only the research team can confirm whether you qualify.
Think this trial could be right for you?
Answer three quick questions written from this study's own rules to see if you may qualify. No account needed to find out.
Check Your Eligibility
About This Trial
The Icahn School of Medicine at Mount Sinai will conduct a randomized controlled trial of a self-management support intervention for predominantly minoritized and low-income adults with chronic obstructive pulmonary disease (COPD). The trial will focus on comprehensive screening and targeted management of barriers to COPD control, incorporating home-based pulmonary rehabilitation and oral steroid …
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
* Age ≥40 years
* Chart-documented COPD with GOLD classifications B or E based on CAT score and number of exacerbations with or without hospitalization determined by electronic health record (EHR) review. GOLD class B and E patients are at increased risk of activity limiting sym…
Contacts